Literature DB >> 2992940

Specific transforming potential of oncogenes encoding protein-tyrosine kinases.

B Mathey-Prevot, D Baltimore.   

Abstract

Several chimeric murine retroviruses were constructed to test whether the gag sequence of Abelson murine leukemia virus (A-MuLV) could influence the in vitro specificity of two sarcoma-inducing oncogenes: src of Rous sarcoma virus and fps of Fujinami sarcoma virus. Although the src- or fps- containing chimerae could transform fibroblasts, they were unable to mimic the action of A-MuLV in causing lymphoid transformation in vitro. A-MuLV-derived gag sequences could, however, functionally replace the 5' end of src and restore the transformation potential of a 5'-truncated src gene. To investigate this functional similarity, we replaced the gag sequence of an A-MuLV virus with the 5' end of src. This recombinant virus behaved like the A-MuLV virus from which it was derived: it transformed both fibroblasts and lymphoid cells in vitro. Taken together, these results suggest that lymphoid transformation in vitro is a specific property of abl and not of src or fps. Furthermore, it shows that a functional homology exists between the gag sequence of A-MuLV and the 5' end of src.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992940      PMCID: PMC554416          DOI: 10.1002/j.1460-2075.1985.tb03849.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

1.  Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Authors:  C D Scher; R Siegler
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

2.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation.

Authors:  N E Rosenberg; D R Clark; O N Witte
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

5.  Characterization of the transforming gene of Fujinami sarcoma virus.

Authors:  T Hanafusa; L H Wang; S M Anderson; R E Karess; W S Hayward; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Localization of the ASV src gene product to the plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; G Jay; I Pastan
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

7.  A cellular protein is immunologically crossreactive with and functionally homologous to the Fujinami sarcoma virus transforming protein.

Authors:  B Mathey-Prevot; H Hanafusa; S Kawai
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

8.  Fujinami sarcoma virus: an avian RNA tumor virus with a unique transforming gene.

Authors:  W H Lee; K Bister; A Pawson; T Robins; C Moscovici; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine.

Authors:  O N Witte; A Dasgupta; D Baltimore
Journal:  Nature       Date:  1980-02-28       Impact factor: 49.962

10.  Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein.

Authors:  J E Buss; M P Kamps; B M Sefton
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

View more
  9 in total

1.  Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants.

Authors:  L Varticovski; G Q Daley; P Jackson; D Baltimore; L C Cantley
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

2.  Myristoylation and the post-translational acquisition of hydrophobicity by the membrane immunoglobulin heavy-chain polypeptide in B lymphocytes.

Authors:  S Pillai; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Recombinants within the tyrosine kinase region of v-abl and v-src identify a v-abl segment that confers lymphoid specificity.

Authors:  B Mathey-Prevot; D Baltimore
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

4.  Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.

Authors:  B Mathey-Prevot; G Nabel; R Palacios; D Baltimore
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  The malignant histiocytosis sarcoma virus, a recombinant of Harvey murine sarcoma virus and Friend mink cell focus-forming virus, has acquired myeloid transformation specificity by alterations in the long terminal repeat.

Authors:  J Friel; D Hughes; I Pragnell; C Stocking; C Laker; J Nowock; W Ostertag; R A Padua
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Mutational activation of c-raf-1 and definition of the minimal transforming sequence.

Authors:  G Heidecker; M Huleihel; J L Cleveland; W Kolch; T W Beck; P Lloyd; T Pawson; U R Rapp
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

7.  cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia.

Authors:  I K Hariharan; J M Adams
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

8.  N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.

Authors:  P Jackson; D Baltimore
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

9.  Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11.

Authors:  I J Mason; D Murphy; M Münke; U Francke; R W Elliott; B L Hogan
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.